Beall P T, Misra L K, Young R L, Spjut H J, Evans H J, LeBlanc A
Calcif Tissue Int. 1984 Jan;36(1):123-5. doi: 10.1007/BF02405304.
Clomiphene citrate, a mixed estrogen agonist-antagonist, protects mature ovariectomized breeder rats from changes in total body calcium and from deterioration of femur structure. Over 6 months, mature ovariectomized rats took up calcium at the rate of 0.7 +/- 0.5 mg/day, while normal controls gained 2.5 +/- 0.7 mg/day (mean +/- SEM) as measured by whole body neutron activation analysis. Injections of clomiphene (20 mg/kg/week) kept ovariectomized rats in positive calcium balance at 2.0 +/- 0.5 mg/day. Reductions in total femur calcium content, cortical thickness, and visible trabeculae of femurs in ovariectomized animals were prevented by chronic clomiphene administration. These results in animals suggest a possible new line of investigation of the use of antiestrogenic drugs as therapeutic agents for hormone-dependent osteoporosis in animals and humans.
枸橼酸氯米芬是一种雌激素激动剂-拮抗剂混合物,可保护成熟的去卵巢繁殖大鼠免受全身钙含量变化及股骨结构退化的影响。通过全身中子活化分析测量,在6个月的时间里,成熟的去卵巢大鼠以0.7±0.5毫克/天的速率摄取钙,而正常对照组则以2.5±0.7毫克/天(平均值±标准误)的速率增加钙含量。注射氯米芬(20毫克/千克/周)可使去卵巢大鼠保持正钙平衡,速率为2.0±0.5毫克/天。长期给予氯米芬可防止去卵巢动物股骨总钙含量、皮质厚度和可见骨小梁的减少。这些动物实验结果提示,抗雌激素药物作为动物和人类激素依赖性骨质疏松症治疗药物的应用可能是一个新的研究方向。